Does the Choice of Acute Treatment Influence Future Ulcer Relapse?

References

• Bodemar Walan G. A Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet 1978; 2: 403–407
   PubMedGoogle Scholar
• Krause U. Long term results of medical and surgical treatment of peptic ulcer. Acta Chir Scand Suppl 1963; 310
   Google Scholar
• Walan A. Studies on peptic ulcer disease with special reference to the effect of 1-hyoscya-mine. Acta Med Scand Suppl 1970; 516
   Google Scholar
• Strom M., Gotthard R., Bodemar G., Walan A. Antacid/Anticholinergic, Cimetidine, and placebo in treatment of active peptic ulcers. Scand J Gastroenterol 1981; 16: 593–602
   PubMed Web of Science ®Google Scholar
• Jönsson K Å, Bodemar G., Norrby K., Walan A., Tysk C. Are endoscopical and/or histological findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid. Scand J Gastroenterol 1988; 23: 199–208
   PubMed Web of Science ®Google Scholar
• Becker U., Andersen C., Linderoff K., Ranlov P. J. Controlled compaison of Novaluzid and cimetidine in duodenal healing and six-month recurrence rate. Scand J Gastroenterol 1984; 19((suppl 98))4, Abstract
   Google Scholar
• Bytzer P., Lauritsen K., Rask-Madsen J. Symptomatic recurrence of healed duodenal and prepyloric ulcers after treatment with ranitidine or high-dose antacid. Scand J Gastroenterol 1986; 21: 765–768
   PubMed Web of Science ®Google Scholar
• Center for Ulcer Research' and Education (CURE). Is duodenal ulcer recurrence more common after cimetidine treatment. Gastroenterology 1980; 78: 1152, Abstract
   Google Scholar
• Hansky J., Korman M. G., Schmidt G. T., Stern A. J., Shaw R. G. Relapse rate of duodenal ulcer after healing with cimetidine or Mylanta II. Gastroenterology 1980; 78: 1179, (5 Part 2), (Abstract) May.
   Google Scholar
• Hentschel K., Schutzek W. Dufek. Relapse rates of duodenal ulcer healed with concentrated antacid or cimetidine. Hepato-gastroenterol 1984; 31: 266–268
   PubMedGoogle Scholar
• Ippoliti A., Elashoff J., Valenzuela J., Cano R., Frankl H., Samlott M., Koretz R. Recurrent ulcer after succesful treatment with cimetidine or antacid. Gastroenterology 1983; 85: 875–880
   PubMed Web of Science ®Google Scholar
• Lam S. K., Hui W. M., Lau W. Y., Branicki F. J., Lai C. L., Lok A. S. F., Ng M. M. T., Fok P. J., Poon G. P., Choi T. K. Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology 1987; 92: 1193–1201
   PubMed Web of Science ®Google Scholar
• Hallerbäck B., Solhaug J. H., Carling L., Clise H., Hallgren T., Kagevi I., Svedberg L. E., Wahlby L. Recurrent ulcer after treatment with cimetidine or sucralfate. Scand J Gastroenterol 1987; 22: 791–797
   PubMed Web of Science ®Google Scholar
• Hentschel E., Schutzek K., Dufek W. Recurrence of duodenal ulcer following treatment with sucralfate and cimetidine. Wien Klin Wochensch (in german) 1984; 96: 153–156
   PubMed Web of Science ®Google Scholar
• Marks I. N., Wright J. P., Lucke W., Girdwood A. H. Relapse rates after initial ulcer healing with sucralfate and cimetidine. Scand J Gastroenterol 1982; 17: 429–432
   PubMed Web of Science ®Google Scholar
• Martin D. F., May S. J., Tweedle D. E. F., Hollanders D., Ravenscroft M. M., Miller J. P. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet 1981; 7–10
   PubMedGoogle Scholar
• Hamilton I., O'Connor H. J., Wood N. C., Bradbury I., Axon AT R. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut 1986; 27: 106–110
   PubMed Web of Science ®Google Scholar
• Kang H. Y., Piper D. W. Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing. Digestion 1982; 23: 73–79
   PubMed Web of Science ®Google Scholar
• Cipollini F., Altilia F. Comparison of tripotassium di-citrato bismuthate (TDB) with ranitidine in healing and relapse of gastric ulcer. Br J Clin Pract 1987; 41(No 4)707–709
   PubMedGoogle Scholar
• Gibinski K., Nowalk A., Marlicz K., Depczynska A., Dzieniszewski J., Milewski B., Gabryelcwicz A., Kosidlos S. Tripotassium dicitrato bismuthate (TDB) in the treatment of peptic ulcerand prevention of ulcer recurrence. Pol Tyg Lek 1984; 39: 1547–1550
   PubMedGoogle Scholar
• Lee F. I., Samlott I. M., Hardman M. Comparison of Tri-potassium Di-citrato Bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet 1985; i: 1299–1301
   Google Scholar
• Shreeve D. R., Klass H. J., Jones P. E. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers. Digestion 1983; 28: 96–101
   PubMed Web of Science ®Google Scholar
• Bianchi Porro G., Lazzaaroni M., Parente F., Petrillo M. The influcence of colloidal bismuth subcitrate on duodenal ulcer relapse. Scand J Gastroenterol 1986; 21: 35–38, (suppl 122)
   PubMedGoogle Scholar
• Bianchi Porro G., Lazzaroni M., Petrillo M., De Nicola C. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine. Lancet 1984; 2: 698
   PubMedGoogle Scholar
• Vantrappen G., Schuurmans P., Rutgeerts P., Janssens J. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer. Scand J Gastroenterol 1982; 17((suppl 80))23–30
   Google Scholar
• Humphries H., O'Leary A. D., Dooley C., O'Morain C A. The effect of two different treatments on Campylobacter pyloridis status in patients with peptic disease. Scand J Gastroent 1987; 22((suppl 135))12, (abstract no 23)
   Google Scholar
• Tytgat G. N. J., Rauws E. A. J., De Koster E. Campylobacter pylori. Scand J Gastroenterol 1988; 23, (suppl 155)
   PubMedGoogle Scholar
• Bardhan K. D., Bianchi Porro G., Bosek Daly M., Hinchliffe R. F. C., Jonsson E, Lazzarone M., Naesdal J., Rikner L., Walan A. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986; 8: 408–413
   PubMed Web of Science ®Google Scholar
• Classen M., Dammann H. G., Comschke W., Hengels K. J., Hutteman W., Londong W., Rehner M., Simon B., Witzel L., Berger J. Kurzzeit-therapie des ulcus duodeni mit omeprazol und ranitidin. Deutsch Med Wschr 1985; 110: 210–215
   PubMed Web of Science ®Google Scholar
• Gustavsson S., Nyrén O., Adami H. O., Forhaug K., Knutsson L., Lööf L., Nyberg A., Wollert S. Omeprazole heals duodenal and prepyloric ulcers faster than cimetidine. — A single centre trial. Gastroenterology 1987; 92: 1490, Abstract no
   Google Scholar
• Lauritsen K., Rune S. J., Bytzer P., Kelbaek H., Rask-Madsen J., Bendtsen F., Linde J., Højlund M., Andersen H. H., Møllman K. M., Nissen V. R., Ovesen L., Schlichting P., Tage-Jensen U., Wullf H. R. Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. N Engl J Med 1985; 312: 958–961
   PubMed Web of Science ®Google Scholar
• Hunt R. H., Melvin M. A., Mills J. G. Gastric function after treatment with cimetidine. Further experience with H₂-receptor antagonists, A. Torsoli, P. E. Lucchelli, R W Brimblecome. Excerpta Medica, Amsterdam. 1980; 119–129
   Google Scholar
• Aadland E., Berstad A. Parietal and chief cell sensitivity to histamine and pentagastrin stimulation before and after cimetidine treatment in healthy subjects. Scand J Gastroenterol 1979; 14: 933–938
   PubMed Web of Science ®Google Scholar
• Aadland E., Berstad A., Granerus G. Augmented parietal cell sensitivity to histamfine after cimetidine treatment in healthy subjects. Scand J Gastroenterol 1981; 16: 87–91
   PubMedGoogle Scholar
• Aadlund E., Berstad A., Granerus G. Effect of cimetidine treatment on parietal and chief cell sensitivity to histamine and on catabolism of histamine in duodenal ulcer patients. Scand J Gastroenterol 1980; 15: 749–754
   PubMedGoogle Scholar
• Bodemar G., Walan A. Two-year follow-up after one year's treatment with cimetidine or placebo. Lancet 1980; i: 38–39
   Google Scholar
• Dronfield M. W., Batchelor A. J., Larkworthy W., Langman M J S. Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects. Gut 1979; 20: 526–530
   PubMed Web of Science ®Google Scholar
• Gudmand-Hoyer E., Jensen B. K., Krag E., Rask-Madsen J., Rahbek J. Prophylactic effect of cimetidine in duodenal ulcer disease. Br Med J 1978; 1: 1095–1097
   PubMed Web of Science ®Google Scholar
• Bardhan K. D. Intermittent treatment of duodenal ulcer with cimetidine. Br Med J 1980; 2: 20–22
   Google Scholar
• Moshal M. G., Gregory M. A., Pillay C., Spitaels J. M. Scand J Gastroenterol 1979; 14((suppl 154))48–51
   Google Scholar
• Gregory M. A., Moshal M. G., Spitaels J. M. Changes in the morphology of villar epithelial cells adjacent to duodenal ulcers during the process of healing. Scand J Gastroenterol 1982; 17: 441–448
   PubMed Web of Science ®Google Scholar
• Malfertheiner P., Bode G., Mader U., Baczako K., Stanescu A., Ditschuneit H. Histologische und ultrastrukturelle befunde in der abheilungsphase des ulcus duodeni. Klin Wochenschr 1985; 63: 1061–1070
   PubMedGoogle Scholar
• Toyey F. I., Husband E. M., Yiuyc Baker L., McPhail G., Hayaray A. O., Clark C. G. Persistent mucosal abnormalities despite healing of duodenal ulceration and one year's maintenance with cimetidine and sucralfate. Dig Dis Sci 1986; 31((suppl 10))4835, Abstract
   Google Scholar